 What the company does Amryt Pharma PLC LON:AMYT sells and develops orphan drugs used to treat rare diseases with two products on the market. Last year, Amryt acquired US group Aegerion Pharmaceuticals out of Chapter 11 bankruptcy protection in a transaction backed by convertible bondholders, creditors and Nasdaq-listed Novelion Therapeutics, Aegerions parent company. 